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The health properties attributed to several fruits (i.e. pomegranates, raspberries, strawberries, 
blackberry, chestnuts, walnuts, pecan), herbs (tea) and seeds (berries seeds) are attributed to an 
important group of natural polyphenols classified as hydrolysable tannins (HT) named Ellagitannins 
(ETs), that have shown in vitro multi-target biological properties relevant to the treatment of several 
human diseases. In vivo, ETs are rather not absorbed, and they are hydrolysed providing mainly 
Ellagic acid (EA). EA is endowed with the same biological properties of ETs and it could be 
considered as the responsible of their health benefits. Unfortunately, EA cannot be exploited for in 
vivo applications because of its poor water solubility (9.7 μg/mL) and accordingly low 
bioavailability.  
At first, aiming to increase EA solubility, an EA solid microdispersion (EA-md) was realized by 
employing only water and low methoxylated pectin, as a food compatible excipient, by applying 
spray drying technology. EA-md showed a 22% (w/w) Drug Loading (DL), a 30 times improved 
water solubility maintaining a remarkable radical scavenging activity [1]. It has been analytically 
characterised and used for in vivo pharmacological treatments in order to evaluate it as potential 
nutraceutical ingredient.  
Adult (3-6 months old) and old (20-22 old months) male mice were chronically administered EA-
md dissolved in the drinking water (about 150 mg / Kg) for 14 days. During this period, animals 
were monitored for the spontaneous motor activity and for curiosity before, during and at the end of 
the EA-md treatment. Adult and old mice were then sacrificed for “ex vivo, in vitro” analysis to test 
the efficiency of noradrenaline release from cortical nerve endings. It is known that noradrenaline 
exocytosis from cortical nerve endings is significantly impaired during ageing. We found that the 
chronic administration of EA-md did not alter the noradrenaline exocytosis from cortical nerve 
endings of adult mice, but significantly recovered the reduced noradrenaline overflow in aged mice. 
Further investigations are needed to explore the cellular cascade of events accounting for the 
beneficial effect.  
In a second step, pomegranate, as a natural source of EA, has been considered to similarly prepare 
and investigate an analogous formulation. Since pomegranate fruit is recognized as one of the most 
important sources of ETs, mainly localized in the by-products obtained after industrial juice 
squeezing, a method to convert the squeezing marcs into a potential nutraceutical ingredient has 
been explored. In particular, Pulsed Ultrasound-Assisted Extraction (PUAE), using just water as 
solvent, resulted to be suitable for extracting the water-soluble bioactive molecules (PEx), whose 
content in hydrolysable tannins, standardized in EA, has been determined. Furthermore, the already 
mentioned spray drying microdispersion has been employed to formulate and to stabilize it over 
time. This last formulation (PEx-md) will be subjected to the already mentioned pharmacological 
experiments in order to study its nutraceutical properties too. 
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